The global microgrid market is witnessing rapid growth, primarily driven by the rising demand for energy resilience and reliability, especially in the face of grid...
CHICAGO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Live4Lali collaborated in a volunteer initiative alongside the SBB Research Group Foundation, which partners with local nonprofits through its Champion A Charity Program.
In the second quarter, Tallinna Sadam earned close to 30 million euros in sales revenue and more than 3 million euros in profit. The revenue for six months was 58 million euros and the profit exceeded 10 million euros. In the second quarter, the volume of investments increased to 8 million euros, in the first half of the year we invested a total of 12 million euros.
MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 10,200 shares of its common stock to fourteen newly-hired employees, with a grant date of August 5, 2025 (the "Grant Date"). The restricted stock units were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of each individual's employment compensation and were granted as an inducement material to his or her acceptance of employment with TELA Bio.
MIAMI, FL, Aug. 08, 2025 (GLOBE NEWSWIRE) -- MIAMI, FL – August 8, 2025 – Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential operating businesses, today announced its financial and operational results for the first fiscal quarter ended June 30, 2025.
AUSTIN, Texas, Aug. 8, 2025 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH) (ehealth.com), a leading private online health insurance marketplace (the "Company"), today announced that on...
CAMBRIDGE, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to new employees. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employees entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).
BRISBANE, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on August 4, 2025, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 99,000 shares of Class A common stock and restricted stock units (RSUs) underlying 48,200 shares of Class A common stock to eight (8) new employees under the Vera Therapeutics, Inc. 2024 Inducement Plan (Inducement Plan). The Compensation Committee approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).
What: FAC's Art in the Park with the Frederick Keys
When: Friday, August 15th 7p, Gates open at 6p
Where: Nymeo Field at Harry Grove Stadium
FREDERICK,...
PHOENIX, Aug. 8, 2025 /PRNewswire/ -- Colossal, the professional fundraiser behind some of today's most dynamic cause-based competitions, has officially launched public voting for...
Q2 2025 revenue of $40.2 million Q2 2025 Adjusted EBITDA of $4.7 million and GAAP Net Income of $0.5 million Paid off $14.9 million balance of 2025 Convertible Notes Entered into a $15.0 million undrawn working capital facility for further operating flexibility and liquidity